Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Feb 2026 for Sangamo Therapeutics, INC, €267.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Nikunj Jain: trading record in brief
Nikunj Jain appears in our data through filings on Sangamo Therapeutics, Inc shares, published by SEC (Form 4). Over a trading history stretching from 22 October 2025 to 24 February 2026, the count stands at 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 26 February 2026 came the latest disclosure, a share grant for €267 in Sangamo Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Nikunj Jain
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
666 shares@ US$0.47253.9% of flowCommon StockSEC:0002089213-26-000004:0
7,721 shares@ US$0.398538.1% of flowCommon StockSEC:0002089213-26-000002:0
578 shares@ US$0.41663.0% of flowCommon StockSEC:0002089213-25-000008:0
6,708 shares@ US$0.6655.1% of flowCommon StockSEC:0002089213-25-000006:0
4 of 4 declarations
